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ABSTRACT 
 
The paper presents data on interaction of candidate genes (S311C PON2, (-6)A/G AGT,  (-1166)A/C 
AGTR1, (-592)C/A IL-10, VNTR IL-1Ra, T113M IL-9, K198N EDN1, (+46)G/A ADRB2, G/A GNB3 (rs.2301339)) with 
oligogenic and continuous characters of chronic glomerulonephritis. The associations of polymorphisms (-6) 
A/G AGT and VNTR IL-1Ra with acute nephritic and hematuric syndromes at onset of the disease (OR = 2.62 
and OR = 2.04, respectively) were defined. It was found that the molecular genetic markers 311SS PON2 and 
(+46)AA ADRB2 were connected with increased creatinine and haematuria in patients with chronic 
glomerulonephritis (p = 0.05 and p = 0.03, respectively). 
Keywords: chronic glomerulonephritis, candidate genes, genetic polymorphism, clinical syndromes of onset, 
creatinine level, hematuria level. 
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INTRODUCTION 
 
Chronic glomerulonephritis (CGN) is the most severe kidneys disease, which takes the dominant 
positions among the most common causes of chronic renal failure (Kamyshova et al, 2016). The disease 
progresses for a long time (during years and decades). It is characterized by a variety of clinical manifestations 
and, in the end, leads to kidney failure, the morphological substrate of which is contracted kidney. This is one 
of the most common kidney diseases (Pirkle and Freedman, 2013; Litovkina et al, 2014a). Chronic 
glomerulonephritis is found in 1% of all autopsies. The disease occurs at any age. Its first symptoms are the 
most often found between 20 and 40 years (Nickolas et al., 2004). The progression of chronic 
glomerulonephritis steadily leads to the end-stage of chronic renal failure, and to increase the number of 
patients, receiving substitutive renal therapy, which requires additional economic expenses for its conducting 
(Ismail et al., 2016). Therefore, further researches, oriented to identifying the mechanisms of occurrence, 
development and progression of chronic glomerulonephritis, remains an important problem of modern 
medicine and nephrology. 
 
In accordance with the above outlined, this work presents the analysis of associations of polymorphic 
markers candidate genes (S311C PON2, (-6)A/G AGT, (-1166)A/C AGTR1,             (-592)C/A IL-10, VNTR IL-1Ra, 
T113M IL-9, K198N EDN1, (+46)G/A ADRB2, G/A GNB3 (rs.2301339)) with oligogenic and continuous characters 
of chronic glomerulonephritis, as well as with clinically significant syndromes of the disease onset. 
 
MATERIALS AND METHODS 
 
The analysis of candidate genes polymorphisms was conducted among 542 people: 238 patients with 
chronic glomerulonephritis and 304 individuals from the control group. The samples of patient with chronic 
glomerulonephritis and the control group included individuals of Russian nationality, who are natives of the 
Central region of Russia and have no relationships with each other. The patients were included in the group of 
medical cases only after making the disease diagnosis, confirmed by clinical and laboratory instrumental 
methods of examination. Clinical and laboratory examinations of patients were carried out on the basis of the 
Department of Nephrology of the Belgorod Regional Clinical Hospital.    
 
Persons with hypertension, as well as those, who had history of diabetes mellitus or it was identified 
during the survey, were excluded from the group.  
 
The venous blood in the amount of 8-9 ml, taken from the cubital vein of proband, was the material 
for the study. The isolation of genomic DNA from peripheral blood was conducted by standard method of 
phenol-chloroform extraction (Miller et al., 1988). The analysis of studied loci was carried by the method of 
polymerase chain reaction of DNA synthesis, using oligonucleotide primers and probes. (Hulkkonen, 2002; 
Sehouli et al, 2003; Lanfear et al, 2005; Prasad et al, 2006; Jalilian et al, 2008; Ramachandran et al, 2009; 
Meroufel et al, 2014). 
 
The genotyping of DNA markers was carried out by the following methods: the analysis of 
polymorphism of restriction fragments length (S311C PON2, (-6)A/G AGT, (-1166)A/C AGTR1, (-592)C/A IL-10, 
VNTR IL-1Ra, T113M IL-9), the analysis of allelic discrimination by the method  of TagMan probes (K198N 
EDN1, (+46)G/A ADRB2, G/A GNB3 (rs.2301339). 
 
The associations of alleles and genotypes of studied DNA markers with specific clinical syndrome at 
the onset of the disease were assessed, using the analysis of 2x2 contingency tables with calculation of 
criterion 2 with Yates correction for continuity and odds ratios (OR) with 95% confidence intervals (CI). In the 
process of comparative analysis of continuous characters distribution among different groups of patients with 
chronic glomerulonephritis (for example, among patients with different genotypes), in order to minimize the 
errors of the 1st kind, connected with obtaining false positive results, the Bonferroni correction was used (the 
calculation of adjusted number of comparable pairs, the level of significance pcor). 
 
In the process of study, the interaction of candidate genes polymorphisms with quantitative indicators 
(the age of onset, the level of creatinine, hematuria and proteinuria, systolic and diastolic blood pressure), the 
median (Me,), interquartile range (Q25-Q75) and Mann-Whitney test were used in comparative analysis of 
genotypes, according to these indicators. 
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RESULTS 
 
238 patients with chronic glomerulonephritis (middle age 39.58 ± 14.58, ranged from 15 to 76 years), 
and 304 individuals from the control group (42.20 ± 6.28 years, ranged from 18 to 79 years, p> 0.05) were 
examined. 
 
During the comparative analysis of allele frequencies and genotypes of studied loci, among patients 
with chronic glomerulonephritis and the individuals from control group, statistically significant differences 
were not found (p> 0.05) (Table 1). 
 
Table 1: Summary information about the studied polymorphisms 
 
Polymorphism 
Studied 
groups 
Minor allele MAF (%) 
HWE 
χ2 p 
T113M IL-9 
T113M IL-9 
VNTR IL-1Ra 
VNTR IL-1Ra 
S311C PON2 
S311C PON2 
(-6)A/G AGT 
(-6)A/G AGT 
(-1166)A/C AGTR1 
(-1166)A/C AGTR1 
G/A GNB3 
G/A GNB3 
(+46)G/A ADRB2 
(+46)G/A ADRB2 
K198N EDN1 
K198N EDN1 
(-592)C/A IL-10 
(-592)C/A IL-10 
Case 
Control 
Case 
Control 
Case 
Control 
Case 
Control 
Case 
Control 
Case 
Control 
Case 
Control 
Case 
Control 
Case 
Control 
(-4257)A IL-13 
(-4257)A IL-13 
5R IL-1Ra 
5R IL-1Ra 
311C PON2 
311C PON2 
(-6)G AGT 
(-6)G AGT 
(-1166)C AGTR1 
(-1166)C AGTR1 
A GNB3 
A GNB3 
(+46)A ADRB2 
(+46)A ADRB2 
198N EDN1 
198N EDN1 
(-592)А IL-10 
(-592)А IL-10 
17.66 
18.64 
4.19 
0.02 
24.58 
28.12 
48.11 
47.69 
26.18 
25.99 
34.18 
31.68 
36.86 
39.93 
17.02 
18.54 
27.73 
22.67 
3.67 
0.22 
3.57 
0.01 
0.17 
0.75 
0.06 
1.38 
1.01 
0.19 
0.24 
0.41 
2.01 
1.26 
0.30 
0.38 
3.42 
0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
Notes: MAF, minor allele frequency; HWE, Hardy–Weinberg equilibrium. P values were calculated using the χ2 
test. 
 
Then we studied the interrelations between considered loci and quantitative pathogenetically 
significant signs of chronic glomerulonephritis. These indicators were the following: the age of manifestation, 
the levels of creatinine, proteinuria and hematuria, systolic blood pressure and diastolic blood pressure. It 
should be noted, that the distribution of these indicators did not correspond to normal distribution, according 
to the criterion of Shapiro-Wilk (p <0.01) (Table 2); due to this, in the process of comparative analysis of the 
genotypes, according to these indicators, the median (Me), interquartile range (Q25-Q75) and Mann-Whitney 
test were used. 
 
Table 2: The distribution of quantitative indicators in patients with chronic glomerulonephritis 
 
Indicators N Me Q25 Q75 W p 
Age 
manifestation, 
years 
238 27.50 17.00 41.00 0.97 <0.01 
Creatinine 
level, umol/L 
238 112.50 93.90 456.00 0.72 <0.01 
  ISSN: 0975-8585 
November – December 2016  RJPBCS   7(6)  Page No. 3225 
Hematuria 
level,  units 
238 6.00 2.00 12.00 0.39 <0.01 
Proteinuria 
level, g/day 
232 0.50 0.20 1.53 0.50 <0.01 
SBP, 
mm Hg 
238 150.00 120.00 170.00 0.96 <0.01 
DBP, 
mm Hg 
237 100.00 80.00 100.00 0.89 <0.01 
Notes: N, sample size; Me, median; Q25 - Q75, interquartile range - the 25th and 75th percentiles; W, Shapiro-
Wilk test. P values were calculated using the Shapiro-Wilk test. 
 
The interaction of polymorphic markers of candidate genes with quantitative pathogenetically 
significant signs of chronic glomerulonephritis was defined for two loci: paraoxonase-2 (S311C PON2), β2- 
adrenoreceptor ((+46) G/A ADRB2) with hematuria and creatinine levels, respectively. 
 
So for the gene S311C PON2 the following results were obtained: in patients with genetic variant of 
311SS, the level of creatinine was significantly higher (median 127.00 mcM/l, Q25-98.30 mcM/l, Q75-537.00 
mcM/l) compared with the group of patients with chronic glomerulonephritis, having genotypes 311SC, 311CC 
PON2 (median 103.00 mcM/l, Q25-Q75 92.00-336.00 mcM/l, p = 0.05). 
 
The interaction between polymorphic marker of gene β2- adrenoreceptor ((+46) G/A ADRB2) with the 
level of hematuria was defined. In patients who are the carriers of genotype (+46) AA, the median level of 
hematuria is 11.00 units, interquartile range is 3.0-25.0 units, that is significantly higher than in the group of 
patients with genetic variants (+46) GG and (+46) GA, according to given  polymorphism (Me - 5.0 units, Q25-
Q75 2.0-12.0 units, p = 0.03.). 
 
The study of clinical syndromes in onset of chronic glomerulonephritis showed, that in 26.7% of 
patients the disease begins with acute nephritic syndrome, in 30.4% - with nephritic syndrome, in 24.4% - with 
urinary syndrome; hematuric syndrome was observed in 18.5% of patients with chronic glomerulonephritis. 
 
The information about statistically significant interaction between two studied polymorphic markers 
of candidate genes ((-6) A/G AGT, VNTR IL-1Ra), with predominance of specific clinical syndrome at the onset 
of the disease, was obtained in the process of the research. Thus, in patients with chronic glomerulonephritis 
with acute nephritic syndrome, the frequency of genetic variant (-6) AG AGT is 67.2%, that is significantly 
higher than the frequency of the genotype as in the control group (43.9%, χ2 = 9.72, p = 0,003, pcor = 0,009, OR 
= 2.62, 95% Cl 1.40-4.96), as in the patients with chronic glomerulonephritis with other syndromes in the onset 
of the disease: urinary (43.4%, χ2 = 5.46, p = 0.020, pcor = 0.060), nephritic (44.6%, χ2 = 5.47, p = 0.019 , pcor = 
0.057), hematuric (47.5%, χ2 = 3.05, p = 0.08). 
 
Also, we set the association of genotypes 2R/2R, 2R/4R of the gene VNTR IL-1Ra with the 
development of hematuric syndrome at the onset of chronic glomerulonephritis. The patients with genotypes 
2R/2R, 2R/4R had this syndrome in 2.5 times often, than patients with genotype 4R/4R (28.4% vs. 11.4%; χ2 = 
8.15, p = 0.005, pcor = 0.015, OR = 2.04, 95% Cl 1.28-3.87). 
 
DISCUSSION 
 
In our work we revealed the association of polymorphisms (-6) A/G AGT and VNTR IL-1Ra with acute 
nephritic and hematuric syndromes at the onset of chronic glomerulonephritis, respectively. Molecular genetic 
markers 311SS PON2 and (+46) AA ADRB2 are connected with increased levels of creatinine and haematuria in 
patients with chronic glomerulonephritis, respectively. 
 
The interrelation of genotype (+46) AA ADRB2 with increased level of hematuria can be explained as 
follows. The renin release occurs with increasing expression of β2-adrenergic receptors of juxtaglomerular 
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apparatus in the kidneys. As a consequence, there is the activation of the renin-angiotensin-aldosterone 
system, (Buraczynska et al, 2006), the main component of which is angiotensin II, leading to systemic and 
local-renal spasm of arterioles with increasing as total peripheral vascular resistance, as renal vascular 
resistance. It also causes increased reabsorption of sodium, acting directly on the renal tubules. It increases 
the hypertrophy of renal structures and enhances the proteinuria. All this ultimately weakens the kidney 
function and may be the cause of hematuria development. 
 
The paper revealed that the genetic marker 311S PON2 correlated with increased level of creatinine in 
patients with chronic glomerulonephritis. According to the literature (Sawant et al., 2010), in which in the 
process of study of oxidative stress and activity of paraoxonase, among 30 hemodialysis-dependent patients, 
20 of which had the primary manifestation in the form of chronic glomerulonephritis, it was found an increase, 
in comparison with the creatinine level control (p <0.001) and decrease of hormone paraoxonase activity by 
more than 30% (p <0.001), that was seen as the decrease of antioxidant protection. It is known, that the 
reduction of antioxidant effects of paraoxonase-2 leads to oxidative stress and sclerosis of renal tissue, and, 
respectively, to decrease in kidneys function (Litovkina et al., 2014b). 
 
It was found that the genotype (-6) AG AGT is a risk marker for the development of acute nephritic 
syndrome at the onset of the disease (OR = 2.62). In the literature, there is the evidence that urinary excretion 
of angiotensinogen, positively correlates with systolic and diastolic blood pressure, as well as with the ratio of 
urine albumin/creatinine. On the basis of these data, it was concluded that the increase of angiotensinogen 
concentration in urine occurs simultaneously with an increase of glomerular endothelial dysfunction (Kobori et 
al., 2009). 
 
CONCLUSION 
 
Thus, as a result of the study, it was found, that genotype (-6) AG of the gene AGT (OR = 2.62) should 
be considered as the marker of acute nephritic syndrome at the onset of chronic glomerulonephritis, and 
genotypes 2R/2R, 2R/4R of the gene VNTR IL-1Ra are the markers of hematuric syndrome formation (OR = 
2.04). The genotype 311SS of the gene PON2  is connected with increased level of creatinine in patients with 
chronic glomerulonephritis and the genotype (+46) AA ADRB2 is associated with increased levels of hematuria 
in this group of patients (p = 0.05 and p = 0.03 respectively). 
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